Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Johnson

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Spine|August 12, 2005
Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusionSteven D Glassman, John R Dimar, Leah Y Carreon, et al.
Orthopedics|March 19, 2009
Sagittal alignment as a risk factor for adjacent level degeneration: a case-control studyMladen O Djurasovic, Leah Y Carreon, Steven D Glassman, et al.
The Spine Journal : Official Journal of the North American Spine Society|October 2, 2007
Clinical outcomes in older patients after posterolateral lumbar fusionSteven D Glassman, Leah Y Carreon, John R Dimar, et al.
The Spine Journal : Official Journal of the North American Spine Society|January 2, 2007
Posterolateral lumbar spine fusion with INFUSE bone graftSteven D Glassman, Leah Carreon, Mladen Djurasovic, et al.
The Spine Journal : Official Journal of the North American Spine Society|May 29, 2007
The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusionSteven D Glassman, Leah Y Carreon, Mitchell J Campbell, et al.
Spine|January 31, 2009
RhBMP-2 versus iliac crest bone graft for lumbar spine fusion in patients over 60 years of age: a cost-utility studyLeah Y Carreon, Steven D Glassman, Mladen Djurasovic, et al.
The Spine Journal : Official Journal of the North American Spine Society|September 23, 2008
Lumbar fusion outcomes stratified by specific diagnostic indicationSteven D Glassman, Leah Y Carreon, Mladen Djurasovic, et al.
Spine|December 19, 2008
RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of ageSteven D Glassman, Leah Y Carreon, Mladen Djurasovic, et al.
Spine|April 1, 2009
Are preoperative health-related quality of life scores predictive of clinical outcomes after lumbar fusion?Leah Y Carreon, Steven D Glassman, Mladen Djurasovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phaseJohn R Johnson, Peter Bross, Martin Cohen, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Spine|August 12, 2005
Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusionSteven D Glassman, John R Dimar, Leah Y Carreon, et al.
Orthopedics|March 19, 2009
Sagittal alignment as a risk factor for adjacent level degeneration: a case-control studyMladen O Djurasovic, Leah Y Carreon, Steven D Glassman, et al.
The Spine Journal : Official Journal of the North American Spine Society|October 2, 2007
Clinical outcomes in older patients after posterolateral lumbar fusionSteven D Glassman, Leah Y Carreon, John R Dimar, et al.
The Spine Journal : Official Journal of the North American Spine Society|January 2, 2007
Posterolateral lumbar spine fusion with INFUSE bone graftSteven D Glassman, Leah Carreon, Mladen Djurasovic, et al.
The Spine Journal : Official Journal of the North American Spine Society|May 29, 2007
The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusionSteven D Glassman, Leah Y Carreon, Mitchell J Campbell, et al.
Spine|January 31, 2009
RhBMP-2 versus iliac crest bone graft for lumbar spine fusion in patients over 60 years of age: a cost-utility studyLeah Y Carreon, Steven D Glassman, Mladen Djurasovic, et al.
The Spine Journal : Official Journal of the North American Spine Society|September 23, 2008
Lumbar fusion outcomes stratified by specific diagnostic indicationSteven D Glassman, Leah Y Carreon, Mladen Djurasovic, et al.
Spine|December 19, 2008
RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of ageSteven D Glassman, Leah Y Carreon, Mladen Djurasovic, et al.
Spine|April 1, 2009
Are preoperative health-related quality of life scores predictive of clinical outcomes after lumbar fusion?Leah Y Carreon, Steven D Glassman, Mladen Djurasovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phaseJohn R Johnson, Peter Bross, Martin Cohen, et al.
Pageof 6